echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > New antibodies can resist multiple new coronavirus variants

    New antibodies can resist multiple new coronavirus variants

    • Last Update: 2021-09-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    New antibodies can resist multiple new coronavirus variants
    New antibodies can resist a variety of new coronavirus variants New antibodies can resist a variety of new coronavirus variants

    Intern reporter Zhang Jiaxin of Science and Technology Daily

    Researchers at Washington University School of Medicine in St.
    Louis, USA have identified an antibody called SARS2-38, which is highly resistant to a variety of virus variants at low doses and is unlikely to be lost when the virus mutates Effectiveness
    .


    Related papers were published on the website of the top international immunology journal "Immunity" recently, marking a new step towards the development of antibody therapy


    The spike protein is the "siege hammer" for the new coronavirus to invade the city of human cells
    .


    Neutralizing antibodies can prevent the virus from infecting cells by binding to the spike protein of the new coronavirus


    In order to find neutralizing antibodies that are effective against multiple mutations, the researchers first immunized mice with a key part of the spike protein called the receptor binding domain
    .


    Then, they extracted the antibody-producing cells and obtained 43 kinds of antibodies that recognize the receptor binding domain


    By measuring the effect of preventing the new coronavirus from infecting cells, the researchers screened these 43 antibodies
    .


    Then, the researchers tested the nine most effective neutralizing antibodies in mice to see if they could protect the mice from viral infections


    The researchers selected the two most effective antibodies in protecting mice from viral infections and tested them with a set of virus variants
    .


    This group of virus variants includes the "worrying" new coronavirus mutant strains Alpha, Beta, Gamma and Delta, as well as the "notable" new coronavirus mutant strains Kapa and Yota, as well as several Potentially threatening mutant strains that are being monitored but not named


    The study found that an antibody called SARS2-38 can easily neutralize all mutant strains
    .


    In addition, the humanized version of SARS2-38 protects mice from diseases caused by two mutant strains: Kappa and a virus containing a spike protein from the beta variant


    "This antibody has both high (which means it works well at low concentrations) and broad (which means it is effective for all variants) neutralization
    .


    " Senior author of the paper, M.


    Next, researchers may consider combining this antibody with another antibody attached to other sites of the viral spike protein to create a combination therapy that is difficult for the virus to resist


    Focus on the new crown pneumonia epidemic
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.